Streamline the process of getting AndroGel 1.62% for your patients. By signing up for AndroGel Access®, you can spend less time doing tasks for your patients, and instead, spend more valuable time with them. All you need to get set up is information about yourself and where you practice.
Get started and create a profile
Create a Profile or Sign In
on AndroGel Access®
Helpful features include online prior authorization (PA) submissions
and live assistance when you need it:
AndroGel Access® helps you determine which forms you’ll need for each patient’s PA. And once you submit, you can access and manage all of your patients’ referrals in one online location.
If you ever have any questions about getting your patients access to AndroGel 1.62%, you can get in touch with a reimbursement specialist by calling
1‑855‑AGEL‑162, Monday through Friday, 8:00 a.m. to 8:00 p.m. EST.
Do you need to know other medications that are covered by your patients’ insurance plans? Benefits verification will indicate other options that are available.
- Avoid unintentional exposure of women or children to AndroGel 1.62%. Secondary exposure to testosterone can produce signs of virilization. Exposure of a pregnant woman to AndroGel may result in potential hazard to the fetus. AndroGel 1.62% should be promptly discontinued until the cause of virilization is identified.
- AndroGel 1.62% is contraindicated in men with breast cancer or known or suspected prostate cancer, and in women who are or may become pregnant or are breastfeeding, as testosterone may cause fetal harm.
Treatment Experience was created...